Article

8 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 77, n° 5
pages 795-806 (novembre 2017)
Doi : 10.1016/j.jaad.2017.02.019
accepted : 3 February 2017
Continuing Medical Education

Spectrum of orocutaneous disease associations : Immune-mediated conditions
 

Jeffrey D. Cizenski, MD a, Pablo Michel, MD a, Ian T. Watson, BA b, Jillian Frieder, MD a, Elizabeth G. Wilder, MD a, John M. Wright, DDS c, M. Alan Menter, MD a,
a Division of Dermatology, Baylor University Medical Center, Dallas, Texas 
b Texas A&M Health Science Center College of Medicine, Bryan, Texas 
c Department of Diagnostic Sciences, Texas A&M College of Dentistry, Dallas, Texas 

Correspondence to: M. Alan Menter, MD, Division of Dermatology, Baylor University Medical Center, 3900 Junius St, Ste 145, Dallas, TX 75246.Division of DermatologyBaylor University Medical Center3900 Junius St, Ste 145DallasTX75246
Abstract

There are a number of diseases that manifest both on the skin and the oral mucosa, and therefore the importance for dermatologists in clinical practice to be aware of these associations is paramount. In the following continuing medical education series, we outline orocutaneous disease associations with both immunologic and inflammatory etiologies.

The full text of this article is available in PDF format.

Key words : chronic ulcerative stomatitis, Crohn's disease, immune-mediated conditions, linear immunoglobulin A bullous dermatosis, lupus erythematosus, mucous membrane pemphigoid, oral cavity, orocutaneous disease, paraneoplastic pemphigus, pemphigus vulgaris, rheumatoid arthritis, scleroderma



 Funding sources: None.
 Dr Menter has served on the advisory board for AbbVie, Allergan, Amgen, Boehringer Ingelheim, Eli-Lilly, Janssen Biotech, and LEO Pharma, been a consultant for AbbVie, Allergan, Amgen, Eli-Lilly, Galderma, Janssen Biotech, LEO Pharma, Novartis, and Pfizer, been an investigator for AbbVie, Amgen, Boehringer Ingelheim, Celgene, Dermira, Eli-Lilly, Janssen Biotech, LEO Pharma, Merck, Neothetics, Novartis, Pfizer, Regeneron, and Syntrix, and has been a speaker for AbbVie, Amgen, Janssen Biotech, and LEO Pharma. Dr Menter has received grants from AbbVie, Amgen, Boehringer Ingelheim, Celgene, Dermira, Janssen Biotech, LEO Pharma, Merck, Neothetics, Novartis, Pfizer, Regeneron, and Syntrix and has received honoraria from AbbVie, Allergan, Amgen, Boehringer Ingelheim, Eli-Lilly, Galderma, Janssen Biotech, LEO Pharma, Novartis, and Pfizer. The other authors have no conflicts of interest to declare.
 Date of release: November 2017
 Expiration date: November 2020
 Reprints not available from the authors.



© 2017  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline